B. Yi

Abelacimab for Prevention of Venous Thromboembolism.

G. Raskob, H. Büller, P. Verhamme, 2021, The New England journal of medicine.

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa

C. Cullen, Émilie Simard, N. Al-Saady, 2021, Journal of thrombosis and haemostasis : JTH.